Navigation Links
Mayo Clinic researchers apply regenerative medicine to battlefield injuries

ROCHESTER, Minn. -- Mayo Clinic researchers are part of the second phase of a national consortium that focuses on developing innovative medical treatments for wounded veterans. Mayo's role will emphasize peripheral nerve regeneration. Mayo's principal investigator is Anthony Windebank, M.D., a neurologist and deputy director for discovery in the Mayo Clinic Center for Regenerative Medicine. Other organizations will focus on head and face trauma, burns, transplants and other conditions.

"The opportunity to work together with a multidisciplinary, multi-institutional team that will create new therapies for our injured service members is a privilege, and we are proud that Mayo Clinic will be able to make a contribution to this effort," says Dr. Windebank. Other Mayo investigators include Michael Yaszemski, M.D., Ph.D., biomedical engineering and orthopedics; Allen Bishop, M.D., orthopedics; Alexander Shin, M.D., orthopedics; and Robert Spinner, M.D., neurologic surgery.

The consortium -- the Armed Forces Institute of Regenerative Medicine (AFIRM) -- is part of a national effort created to address the health care challenges of severely injured veterans returning from Afghanistan and Iraq. It is funded by the Army Medical Research and Materiel Command, in conjunction with the Office of Naval Research and the National Institutes of Health.

The first phase of AFIRM, which began in 2008, resulted in clinical studies of face transplantation, minimally invasive surgery for craniofacial injuries, a lower-dose anti-rejection regimen after kidney transplantation, scar reduction treatments, fat grafting for reconstructive surgery and new treatments for burns. The second phase (AFIRM-II) is a five-year, $75 million project and will focus on developing clinical therapies.

AFIRM-II will build on the efforts of the first five years, using regenerative medicine to develop new products and therapies to repair battlefield injuries. Regenerative medicine employs cell therapy (including stem cells), tissue and biomaterials engineering, and transplants to enable the body to repair, replace, restore and regenerate damaged tissues and organs. It will accelerate the rate at which biomaterials and technologies are converted into therapies to restore lost tissue and function. These products and therapies also will serve civilian trauma and burn patients.

"The Mayo Clinic Center for Regenerative Medicine is honored to partner in this national effort poised to transform the care of severely wounded veterans. Advances in regenerative technologies promise unprecedented benefits for patients, their families and society," says Andre Terzic, M.D., Ph.D., the Michael S. and Mary Sue Shannon Family Director, Center for Regenerative Medicine, and Marriott Family Professor of Cardiovascular Diseases Research at Mayo Clinic.

The core academic partners of AFIRM-II are Mayo Clinic; Brigham and Women's Hospital; Case Western Reserve University; Cleveland Clinic; Georgia Institute of Technology; Jewish Hospital; Johns Hopkins University; Livionex Inc.; Massachusetts General Hospital; New York University School of Medicine; Northwestern University; Oregon Health & Science University; Radboud University Medical Center; Research Foundation of SUNY; Rice University; Stanford University School of Medicine; Rutgers, The State University of New Jersey; Southwest Research Institute, Stratatech Corporation; The Ohio State University College of Medicine; Tufts University; University of California, Los Angeles; University of Cincinnati, University of Connecticut; University of Florida; University of Louisville School of Medicine; University of Maryland School of Medicine, University of Michigan; University of Pittsburgh; UW Medicine; Vanderbilt University Medical Center; and Wake Forest University School of Medicine (Wake Forest Baptist Medical Center). These core partners are supported by a large number of industrial collaborators and participating health care companies that have expressed an interest in the commercialization of new products and therapies emerging from AFIRM's research program.


Contact: Jennifer Schutz
Mayo Clinic

Related medicine news :

1. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
2. First targeted nanomedicine to enter human clinical studies
3. Clinical insight improves treatment with new lung cancer drug
4. Clinical news alert from the American Academy of Orthopaedic Surgeons
5. Mayo Clinic launches whole genome breast cancer study
6. Mayo Clinic offers newly approved treatment for acid reflux disease
7. NYU Langone experts present research, clinical advances at neurosurgeons meeting
8. Mayo Clinic breast cancer study finds new type of mutation
9. Kroenke honored for outstanding contributions in clinical research training
10. Awards celebrate clinical research that can improve health and alleviate suffering
11. Association for Psychological Science, SAGE launch Clinical Psychological Science
Post Your Comments:
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... ... 2015 , ... Dr. Thomas Dunlap and Dr. Patrick Coleman ... with Emergency Medicine at St., Joseph Health System’s Santa Rosa Memorial Hospital , ... in similar ways and require time-critical intervention to avoid large area heart damage and ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... in central Michigan, have come together on Thanksgiving Day to share the things ... for viewing on the Serenity Point YouTube channel, patients displayed what they wrote ...
(Date:11/26/2015)... VA (PRWEB) , ... November 26, 2015 , ... ... an American Express Travel Representative. As a franchise owner, Somu now offers travelers, ... of cruise, destination wedding packages, private cruise sales, as well as, cabin upgrades ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... , Nov. 26, 2015 ... addition of the "2016 Global Tumor ... Country Volume and Sales Segment Forecasts, Innovative ... report to their offering. --> ... of the "2016 Global Tumor Marker ...
(Date:11/26/2015)... 26 november 2015 AAIPharma Services ... geplande investering aan van ten minste $15,8 ... en het mondiale hoofdkantoor in ... resulteren in extra kantoorruimte en extra capaciteit ... groeiende behoeften van de farmaceutische en biotechnologische ...
(Date:11/26/2015)... -- --> --> Juntendo ... optimal contrast weighting of MRI for patients with Multiple ... research agreement with SyntheticMR in order to use SyMRI in ... possible to generate multiple contrast images from a single scan ... thus making it possible to both fine tune images and ...
Breaking Medicine Technology: